TVTX
Search by
TICKER SYMBOL
TICKER SYMBOL
OptionsHawk Content
Small Biotech with Strong Launch Sees Calls Accumulate, Potential M&A Target
Nov 27, 2024
Travere (TVTX) is a Biotech I wrote on in late August with options activity suggesting a move higher and shares have since doubled. TVTX has...
Small Cap Biotech in Kidney Diseases with Bullish Options Positioning
Aug 27, 2024
Travere Therapeutics (TVTX) is worth taking a closer look as December 2025 short put open interest surged to 4,976 after sales at $3 on 8/26...
Small Cap Biotech in Strong Trend with Bullish Open Interest
Jul 25, 2024
Small Cap Options Flow Travere Therapeutics (TVTX) is a small cap biotech that has shown great relative strength since May and last week saw an...
Upside Call Spreads Bought in Biotech with Potential Blockbuster Near Approval
Jul 19, 2022
Travere Therapeutics (TVTX) unusual buy of 1500 August $25 calls for $2.30, a $1.5B Biotech. Travere currently has a base commercial business that generated $200M...
Market Recap 8-4-2021 (MSFT, ULTA, H, ADM, GM, USFD, CAR, U, RBLX, WYNN, CVNA, LOW, TCOM, LYV, FL, W, DASH, NOVA, PBR, DVN, MARA, SPGI, NMIH, VIRT, COMP, MA, FISV, COF, GS, NVAX, TVTX, FLGT, NVST, PFE, BNTX, OMI, NGM, RDHL, DVAX, GE, CARR, CMI, ZI, FSLY, ADI, WDC, AMBA, AMD, IIVI, FTNT)
Aug 04, 2021
Unusual Call Buying in Two Biotechs with Q3 Catalysts
Aug 04, 2021
NGM Bio (NGM) a $1.6B Biotech jumping here, no confirmed earnings date yet but supposed to be this week, seeing 2450 October $22.50 calls bought...